These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9935217)

  • 1. Efficient adenoviral transfer of NF-kappaB inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosis.
    Bakker TR; Reed D; Renno T; Jongeneel CV
    Int J Cancer; 1999 Jan; 80(2):320-3. PubMed ID: 9935217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappaB kinetics predetermine TNF-alpha sensitivity of colorectal cancer cells.
    Zwacka RM; Stark L; Dunlop MG
    J Gene Med; 2000; 2(5):334-43. PubMed ID: 11045427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells.
    Franco AV; Zhang XD; Van Berkel E; Sanders JE; Zhang XY; Thomas WD; Nguyen T; Hersey P
    J Immunol; 2001 May; 166(9):5337-45. PubMed ID: 11313369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the transcription factor nuclear factor-kappa B by adenoviral-mediated expression of I kappa B alpha M results in tumor cell death.
    Feig BW; Lu X; Hunt KK; Shan Q; Yu D; Pollock R; Chiao P
    Surgery; 1999 Aug; 126(2):399-405. PubMed ID: 10455913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis.
    Soares MP; Muniappan A; Kaczmarek E; Koziak K; Wrighton CJ; Steinhäuslin F; Ferran C; Winkler H; Bach FH; Anrather J
    J Immunol; 1998 Nov; 161(9):4572-82. PubMed ID: 9794384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death.
    Batra RK; Guttridge DC; Brenner DA; Dubinett SM; Baldwin AS; Boucher RC
    Am J Respir Cell Mol Biol; 1999 Aug; 21(2):238-45. PubMed ID: 10423407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB.
    Wang CY; Cusack JC; Liu R; Baldwin AS
    Nat Med; 1999 Apr; 5(4):412-7. PubMed ID: 10202930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas.
    Weaver KD; Yeyeodu S; Cusack JC; Baldwin AS; Ewend MG
    J Neurooncol; 2003 Feb; 61(3):187-96. PubMed ID: 12675310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of NF-kappa B inhibition on TNF-alpha-induced apoptosis in human RPE cells.
    Yang P; McKay BS; Allen JB; Jaffe GJ
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2438-46. PubMed ID: 15223828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of tumor necrosis factor-mediated apoptosis of oral squamous cell carcinoma cells by adenovirus-mediated gene transfer of NF-kappaB inhibitor.
    Chen S; Fribley A; Wang CY
    J Dent Res; 2002 Feb; 81(2):98-102. PubMed ID: 11827262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
    Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
    Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB activation is related to the resistance of lung cancer cells to TNF-alpha-induced apoptosis.
    Kim JY; Lee S; Hwangbo B; Lee CT; Kim YW; Han SK; Shim YS; Yoo CG
    Biochem Biophys Res Commun; 2000 Jun; 273(1):140-6. PubMed ID: 10873576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
    Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
    Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells.
    Karacay B; Sanlioglu S; Griffith TS; Sandler A; Bonthius DJ
    Cancer Gene Ther; 2004 Oct; 11(10):681-90. PubMed ID: 15332116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappaB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis.
    Xu Y; Bialik S; Jones BE; Iimuro Y; Kitsis RN; Srinivasan A; Brenner DA; Czaja MJ
    Am J Physiol; 1998 Oct; 275(4):C1058-66. PubMed ID: 9755059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of NF-kappaB renders human juvenile costal chondrocyte cell lines sensitive to TNF-alpha-mediated cell death.
    Yoon HS; Kim HA; Song YW
    Rheumatol Int; 2006 Jan; 26(3):201-8. PubMed ID: 15703956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells through inhibition of nuclear factor-kappaB by an IkappaBalpha "super-repressor".
    Muenchen HJ; Lin DL; Walsh MA; Keller ET; Pienta KJ
    Clin Cancer Res; 2000 May; 6(5):1969-77. PubMed ID: 10815922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral gene transfer of ABIN-1 protects mice from TNF/galactosamine-induced acute liver failure and lethality.
    Wullaert A; Wielockx B; Van Huffel S; Bogaert V; De Geest B; Papeleu P; Schotte P; El Bakkouri K; Heyninck K; Libert C; Beyaert R
    Hepatology; 2005 Aug; 42(2):381-9. PubMed ID: 16025521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells.
    McDade TP; Perugini RA; Vittimberga FJ; Carrigan RC; Callery MP
    J Surg Res; 1999 May; 83(1):56-61. PubMed ID: 10210643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of transcription factor nuclear factor-kappaB by a mutant inhibitor-kappaBalpha attenuates resistance of human head and neck squamous cell carcinoma to TNF-alpha caspase-mediated cell death.
    Duffey DC; Crowl-Bancroft CV; Chen Z; Ondrey FG; Nejad-Sattari M; Dong G; Van Waes C
    Br J Cancer; 2000 Nov; 83(10):1367-74. PubMed ID: 11044363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.